 | Up a level |
Kang, Jeehoon; Abdul Ghapar, Abdul Kahar; Selvaraj, Kamaraj; Hur, Seung-Ho; Tam, Chor Cheung; Jang, Yangsoo; Chae, In-Ho; Kandzari, David E; Kirtane, Ajay J; Latib, Azeem; Kedhi, Elvin; Lung, Te-Hsin; You, So-Jeong; Windecker, Stephan; Stone, Gregg W; Kim, Hyo-Soo (2024). One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention - Onyx ONE Clear 2-Year Results. Circulation reports, 6(8), pp. 333-340. 10.1253/circrep.CR-24-0037
Gragnano, Felice; Cao, Davide; Pirondini, Leah; Franzone, Anna; Kim, Hyo-Soo; von Scheidt, Moritz; Pettersen, Alf-Åge R; Zhao, Qiang; Woodward, Mark; Chiarito, Mauro; McFadden, Eugene P; Park, Kyung Woo; Kastrati, Adnan; Seljeflot, Ingebjørg; Zhu, Yunpeng; Windecker, Stephan; Kang, Jeehoon; Schunkert, Heribert; Arnesen, Harald; Bhatt, Deepak L; ... (2023). P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events. Journal of the American College of Cardiology, 82(2), pp. 89-105. Elsevier 10.1016/j.jacc.2023.04.051
Kang, Jeehoon; Park, Kyung Woo; Palmerini, Tullio; Stone, Gregg W; Lee, Michael S; Colombo, Antonio; Chieffo, Alaide; Feres, Fausto; Abizaid, Alexandre; Bhatt, Deepak L; Valgimigli, Marco; Hong, Myeong-Ki; Jang, Yangsoo; Gilard, Martine; Morice, Marie-Claude; Park, Duk-Woo; Park, Seung-Jung; Jeong, Young-Hoon; Park, Jiesuck; Koo, Bon-Kwon; ... (2019). Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs. Thrombosis and haemostasis, 119(1), pp. 149-162. Thieme 10.1055/s-0038-1676545
